What's new

ARPANSA has granted the Australian Nuclear Science and Technology Organisation (ANSTO) an amended license to allow for the limited production of molybdenum-99 in order to sustain supply.

At ARPANSA, we set the safety standard sets limits for exposure to radio frequency (RF) electromagnetic energy (EME) that is emitted by mobile phones and other wireless technologies. These limits are set well below levels at which harm to people may occur. The operating frequencies of the 5G network are included within the limits set by the ARPANSA safety standard.

We’re excited to announce that we have installed a new linear accelerator (linac) at ARPANSA, to continue ensuring any Australians undergoing medical procedures receive the correct amount of radiation.

The Governor-General has reappointed Dr Carl-Magnus Larsson as the CEO of ARPANSA for a term of three years.

We’ve released national advice for light-based cosmetic treatments in Australia for both patients and practitioners. 

The final report for the Integrated Regulatory Review Service (IRRS) mission to Australia has been released.

ARPANSA scientists have reviewed the recent National Toxicology Program (NTP) animal studies which looked at whether exposure to radiofrequency (RF) radiation causes any health effects, including cancer, in rats and mice.

The ARPANS Regulations 1999 and ARPANS Licence Charges Regulations 2000 have been repealed and replaced.

A study led by ARPANSA, published with the British Medical Journal Open, found no link between the use of mobile phones in Australia and incidence of brain cancers.

Today, the Integrated Regulatory Review Service (IRRS) mission was officially opened at ARPANSA. Officials emphasised the mission, reviewing Australia’s nuclear protection and radiation safety regulatory framework, shows international openness and transparency and a commitment to improvement. 

On 19 September 2018, at the International Atomic Energy Agency (IAEA) General Conference in Vienna, ARPANSA’s Deputy Chief Executive Officer, Gillian Hirth, alongside the Deputy Chairman of the Board of the Dutch Authority for Nuclear Safety and Radiation Protection (ANVS), Marco Brugmans, signed a memorandum of understanding (MoU).

ARPANSA has been busy building a new bunker in preparation for the installation of a new, state-of-the-art medical linear accelerator (linac)

On 29 June 2018, the CEO of ARPANSA, Dr Carl-Magnus Larsson, issued the Australian Nuclear Science and Technology Organisation with a direction under section 41(1A) of the Australian Radiation Protection and Nuclear Safety Act 1998.